Cargando…

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment

Despite systematic screening and improved treatment strategies, the prognosis remains worse in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) compared to patients with idiopathic/hereditary pulmonary arterial hypertension (IPAH). We aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hjalmarsson, Clara, Kjellström, Barbro, Jansson, Kjell, Nisell, Magnus, Kylhammar, David, Kavianipour, Mohammad, Rådegran, Göran, Söderberg, Stefan, Wikström, Gerhard, Wuttge, Dirk M., Hesselstrand, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326683/ https://www.ncbi.nlm.nih.gov/pubmed/34350280 http://dx.doi.org/10.1183/23120541.00854-2020

Ejemplares similares

Predicting mortality during long-term follow-up in pulmonary arterial hypertension
por: Kylhammar, David, et al.
Publicado: (2021)

Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016
por: Kjellström, Barbro, et al.
Publicado: (2019)

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2022)

Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study
por: Hjalmarsson, Clara, et al.
Publicado: (2020)

Longitudinal changes in risk status in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2020)

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2020)

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2019)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
por: Lindholm, Anthony, et al.
Publicado: (2022)

Underfilling decreases left ventricular function in pulmonary arterial hypertension
por: Sjögren, Hannah, et al.
Publicado: (2021)

Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
por: Sandqvist, Anna, et al.
Publicado: (2017)

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
por: Wuttge, Dirk M, et al.
Publicado: (2021)

Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2021)

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2019)

Airway resistance and reactance are affected in systemic sclerosis
por: Aronsson, David, et al.
Publicado: (2015)

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2014)

Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre‐capillary pulmonary hypertension
por: Bredfelt, Anna, et al.
Publicado: (2018)

Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
por: Lindholm, Anthony, et al.
Publicado: (2019)

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2022)

Pulmonary blood density quantified by CMR is reduced in newly diagnosed systemic sclerosis, consistent with pulmonary arteriolar proliferation
por: Kanski, Mikael, et al.
Publicado: (2011)

Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals – a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes
por: Kanski, Mikael, et al.
Publicado: (2013)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study
por: Andréasson, Kristofer, et al.
Publicado: (2020)

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis – a Longitudinal Study
por: Juhl, Pernille, et al.
Publicado: (2020)

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2023)

Myocardial perfusion using cardiac magnetic resonance: Evidence of decreased global myocardial perfusion in patients with systemic sclerosis with possible gender differences
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study
por: Gyllenhammar, Tom, et al.
Publicado: (2018)

Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial pressure in pulmonary hypertension, with and without systemic sclerosis
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
por: Hamberg, Viggo, et al.
Publicado: (2023)

Novel Insight into How Nurses Working at PH Specialist Clinics in Sweden Perceive Their Work
por: Ivarsson, Bodil, et al.
Publicado: (2020)

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes
por: Radstake, Timothy R. D. J., et al.
Publicado: (2009)

A call for refining the role of humic-like substances in the oceanic iron cycle
por: Whitby, Hannah, et al.
Publicado: (2020)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
por: Hesselstrand, Roger, et al.
Publicado: (2021)

Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation
por: Lundgren, Jakob, et al.
Publicado: (2015)

Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2018)

Mortality and cancer morbidity among cadmium-exposed workers
por: Kjellström, Tord, et al.
Publicado: (1979)

Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
por: Kjellström, Barbro, et al.
Publicado: (2020)

The Odyssey from Symptom to Diagnosis of Pulmonary Hypertension from the Patients and Spouses Perspective
por: Ivarsson, Bodil, et al.
Publicado: (2021)

A call to arms: on refining Plasmodium vivax microsatellite marker panels for comparing global diversity
por: Sutton, Patrick L
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ov5onvp5ogegf21lv4aehiep48